Close Menu

NEW YORK (360Dx) – Quest Diagnostics today reported 3 percent year-over-year growth in revenues for the second quarter, but fell short of analysts' average estimate.

Revenue was $1.92 billion for the three-month period ended June 30, up from $1.86 billion in the second quarter 2017. The consensus Wall Street revenue estimate for the quarter was $1.95 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.